CareLit Fachartikel

Taxol Resistance and its Reversal by Synthetic Isoprenoids in Human Bladder Cancer Cell Line

M. Nakagawa, H. Enokida, T. Gotanda, T. Tachiwada, Y. Imazono, H. Kubo, K. Nishiyama, S. Suzuki, K. Inomata, T. Kishiye · Aktuelle Urologie · 2003 · Heft 04 · S. 250-252

Dokument
1130798
CareLit-ID
Jahr
2003
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Aktuelle Urologie
Autor:innen
M. Nakagawa, H. Enokida, T. Gotanda, T. Tachiwada, Y. Imazono, H. Kubo, K. Nishiyama, S. Suzuki, K. Inomata, T. Kishiye
Ausgabe
Heft 04 / 2003
Jahrgang 34
Seiten
250-252
Erschienen: 2003-01-01 00:00:00
ISSN
0001-7868

Zusammenfassung

Abstract PURPOSE: We investigated the mechanism of action of reversal agents for taxol-resistance in bladder cancers. MATERIALS AND METHODS: We isolated a taxol-resistant cell line (KK47/TX30) from a human KK47 bladder cancer cell line (KK47/WT). We characterized KK47/TX30 cells and screened reversal agents for taxol-resistance. RESULTS: KK47/TX30 cells exhibited approximately 700-fold resistance to taxol and cross-resistance to Vinca alkaloids and topoisomerase II inhibitors. Western blot analysis demonstrated P-glycoprotein (P-gp) overexpression in taxol-resistant cells. Drug accumulation and efflux studies sh…

Schlagworte

Taxol-resistance P-glycoprotein isoprenoid bladder cancer Cyclohexane Alkaloids Benzene Aktuelle Urologie